Prevention of Future Deaths reports · 2023

Reginald Bourn

Regulation 28 report to prevent future deaths, reference 2023-0288, written 8 Aug 2023. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.

Date of report8 Aug 2023
Reference2023-0288
DeceasedReginald Bourn
CoronerCaroline Topping
Coroner areaSurrey
CategoryHospital Death (Clinical Procedures and medical management) related deaths
Sourcejudiciary.uk record · original PDF
Responses published3

The report

Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.

REGULATION 28 REPORT TO PREVENT FUTURE DEATHS  

THIS REPORT IS BEING SENT TO: 

1. 
2. 

, Chief Executive, Health Education England 
, Chief Executive, National Institute for Health 

and Care Excellence 

1 

CORONER 

I am Caroline Topping assistant coroner, for the coroner area of 
Surrey.  

2 

CORONER’S LEGAL POWERS 

I make this report under paragraph 7, Schedule 5, of the Coroners and 
Justice Act 2009 and Regulations 28 and 29 of the Coroners 
(Investigations) Regulations 2013.  

3 

INVESTIGATION and INQUEST 

An inquest into the death of Mr Reginald Edwin Bourn was opened on the 
12th May 2022 and on the 19th June 2023. The inquest was concluded on 
the 27th June 2023. 

Reginald Bourn died at Frimley Park Hospital on the 24th February 2022.  

The cause of death was: 

I a Aspiration of Gastrointestinal Content 
I b Small Bowel Obstruction caused by either a Peritoneal Adhesion or 
Incarceration of an Inguinal Hernia (Resolved) 

The narrative conclusion was: 

Reginald Bourn was admitted to Frimley Park Hospital with acute 
abdominal pain and a distended stomach. Investigations revealed 
prominent small bowel loops but no transition point. He began to vomit. He 
was treated conservatively, and a nasogastric tube was used to 
decompress his stomach. On the 24th February 2022 the tube had fallen 
out by 4.30 by which time he no longer felt nauseous. He began to vomit 
again, and staff were advised to reinsert the nasogastric tube at 7.02. He 
was seen at a surgical ward round at 9.45 by which time the tube had not 
been reinserted. The plan remained for conservative treatment and 
decompression with a nasogastric tube. He was admitted to a surgical ward 
with a NEWS score of 3 at 10.20. Insertion of the nasogastric tube was 
effected by 11.40. The tube was misplaced into his left lung. Prior to 12.00 
he suffered an acute event resulting in the aspiration of one and a half litres 
of stomach content into his lungs. His condition significantly worsened, his 

1 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 NEWS score was 10 and his blood oxygen level deteriorated to 88%. He 
died from the aspiration of gastrointestinal content. The misplacement of 
the nasogastric tube more than minimally contributed to the death. 
Misplacement of nasogastric tubes into the lungs is a known complication 
of a necessary medical procedure. 

4 

CIRCUMSTANCES OF THE DEATH 

Mr Bourn had an intestinal blockage on admission to hospital which 
required the placement of a nasogastric draining tube to decompress his 
stomach. The first tube came out and a second one was placed by an 
experienced nurse. Shortly thereafter he suffered an acute event and 
aspirated one and a half litres of gastrointestinal content into his left lung. 
A chest X ray was taken. He died shortly thereafter. When read the X ray 
revealed that the tube had been misplaced in the left lung. He died as a 
consequence of the aspiration of gastrointestinal content which was in part 
attributable to the fact that the misplaced tube enabled ingress to the lung 
of the aspirate, and in part because the stomach content had not been 
drained.  

5 

CORONER’S CONCERNS 

During the course of the inquest the evidence revealed matters giving 
rise to concern. In my opinion there is a risk that future deaths could occur 
unless action is taken. In the circumstances it is my statutory duty to 
report to you. 

The MATTERS OF CONCERN are as follows: 

1.  The expert and clinical evidence was that the insertion of any 

nasogastric tube is complicated and misplacement into a lung can 
occur because of the proximity of the trachea to the oesophagus.  

2.  Examples of nasogastric decompression tubes and nasogastric 

feeding tubes were provided in evidence. The feeding tubes have 
instructions both as to how to insert them and as to how to ensure 
that they are correctly placed. The decompression tubes have 
neither.  

3.  The expert evidence was that there is national guidance in relation to 

the placement of nasogastric feeding tubes but not nasogastric 
decompression tubes. However, as exemplified by this case, 
misplacement of either can prove fatal.  

4.  The clinicians who investigated the death could not find any 

nationally recognised protocols dealing with the use of, and training 
on the insertion of, nasogastric decompression tubes nor for 
checking whether they are appropriately placed. 

5.  The Healthcare Safety Investigation Branch independent report 
12019/006 made recommendations in December 2020 on the 
placement of feeding nasogastric tubes.  It found that the use of pH 
strips is potentially unreliable and incorrect X ray confirmation and 
interpretation is the most common cause of misplacement incidents.  

2 

 
 
 
 
 
 
 
 
 
 
 
 
 6.  One of the recommendations made was for a national standardised 

competency-based training programme for nasogastric tube 
placement and confirmation by pH testing.  

7.  It appears that there is no suggested training nor national guidance 
in relation the placement of nasogastric decompression tubes. 

6 

ACTION SHOULD BE TAKEN 

In my opinion action should be taken to prevent future deaths and I 
believe you [AND/OR your organisation] have the power to take such 
action. 

7 

YOUR RESPONSE 

You are under a duty to respond to this report within 56 days of the date of 
this report, namely by 3rd October 2023. I, the coroner, may extend the 
period. 

Your response must contain details of action taken or proposed to be 
taken, setting out  the timetable for action. Otherwise, you must explain 
why no action is proposed. 

8 

COPIES and PUBLICATION 

I have sent a copy of my report to the Chief Coroner and to the following 
Interested Persons: 

Mr Bourn’s Family  
Frimley Park Hospital  

I am also under a duty to send a copy of your response to the Chief 
Coroner and all  interested persons who in my opinion should receive 
it. 

I may also send a copy of your response to any other person who I believe 
may find it useful or of interest. 

The Chief Coroner may publish either or both in a complete or redacted 
or summary form. He may send a copy of this report to any person who 
he believes may find it useful or of interest. 

You may make representations to me, the coroner, at the time of your 
response, about the release or the publication of your response. 

9 

Caroline Topping, 8th August 2023 

3

Responses

3 responses published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.

Response from Medicines and Healthcare Products Regulatory Agency (PDF)
10 South Colonnade 
Canary Wharf 
London 
E14 4PU 
United Kingdom 
gov.uk/mhra 

Ms Caroline Topping 
HM Assistant Coroner 

27 November 2023 

Dear Ms Topping, 

: Regulation 28 Report - Reginald Edwin Bourn 

I would like to thank you for your email dated 1 November 2023 regarding the Regulation 28 
Report for  the  death  of  Reginald  Edwin  Bourn  and  the  subsequent  response  from 

 Chief Executive, NICE, regarding instructions for nasogastric decompression tubes. 
I  would  like  to  express  our  condolences  to  the  Bourn  family  and  hope  that  the  information 
provided below may help at this difficult time. 

Firstly, it may be helpful if to provide background information relating to the MHRA and the 
work we carry out. The MHRA is the executive Agency of the Department of Health and Social 
Care that acts on behalf of the Ministers to protect and promote public health and patient safety 
by  ensuring  that  medicines,  healthcare products  and medical  equipment,  including medical 
devices, are used safely and meet appropriate standards of safety, quality, performance, and 
effectiveness.  The  MHRA  assesses  the  balance  of  risks  and  benefits  of  medical  devices 
throughout  their  use  in  clinical  practice  in  a  process  known  as  vigilance.  This  involves  the 
collection of information and assessment of any potential risks, followed, when necessary, with 
communications  and  regulatory  action  to  minimise  those  risks.  Where  serious  incidents 
involving  medical  devices  have  been  reported  to  other  authorities  including  the  Police, 
Coroners and the Health and Safety Executive (HSE), the MHRA provides technical expertise 
and facilitates independent testing if required. The MHRA ensures any concerns raised from 
these investigations are disseminated to the health service to prevent further incidents or taken 
up with the manufacturer. 

Following receipt of the Regulation 28 Report we have considered point two in the matters of 
concern:  “Feeding  tubes  have  instructions  both  as  to  how  to  insert  them  and  as  to  how to 
ensure  that  they  are  correctly  placed.  The  decompression  tubes  have  neither”.  We  have 
reached out to the manufacturers of nasogastric tubing to confirm their primary intended use 
and  to  review  their  instructions  for  use  (IFU)  for  both  feeding  and  decompression  tube 
placement.  

 
 
  
 
 
 
 
 
 
 
 
 We expect to complete the initial review of the IFUs by 4 January 2024. Following this review, 
we will work with manufacturers to update their IFU where applicable. If updates are made, 
the MHRA is of the opinion that they should issue a Field Safety Notice (FSN) to highlight the 
changes to clinicians, and ensure that their staff are fully trained in the changes so that they 
can provide advice to clinicians where necessary. 

I would like to thank you once again for raising this important safety issue to our attention and 
I hope the information provided is useful and I will provide a summary of any planned actions 
by 4 January 2024. In the meantime, please do not hesitate to contact me if I can be of further 
assistance. 

Yours sincerely, 

Chief Safety Officer 
Medicines and Healthcare products Regulatory Agency
Response from NHS England (PDF)
Caroline Topping 
Surrey HM Coroner’s Court  
Station Approach 
Woking  
GU22 7AP 

Dear Coroner, 

National Medical Director  
NHS England  
Wellington House 
133-155 Waterloo Road  
London 
SE1 8UG 

27 December 2023  

Re: Regulation 28 Report to Prevent Future Deaths – Reginald Edwin Bourn 
who died on 24 February 2022.  

Thank  you  for  your  Report  to  Prevent  Future  Deaths  (hereafter  “Report”)  dated  8 
August 2023 concerning the death of Reginald Edwin Bourn on 24 February 2022. In 
advance of responding to the specific concerns raised in your Report, I would like to 
express my deep condolences to Reginald’s family and loved ones. NHS England are 
keen to assure the family and the coroner that the concerns raised about Reginald’s 
care have been listened to and reflected upon.  

In  your  Report,  some  of  your  concerns  related  to  the  lack  of  instructions,  national 
guidance, and protocols/training on the insertion of nasogastric decompression tubes. 
I will address these within the realms of NHS England’s statutory powers, roles and 
responsibilities.  Where I am unable to assist, I hope to provide you with some direction 
on either where such information can be obtained or from what organisation. 

Whilst NHS England would not routinely provide national guidance on the insertion of 
nasogastric decompression tubes, there is existing national guidance in the form of 
the Royal Marsden Manual, who have particular expertise in this area.  The manual 
has a section on ‘Insertion of a nasogastric drainage tube’ which contains background 
information and specific procedural guidance for the insertion and removal of these 
tubes, including around pH testing. This is aimed at clinical nursing staff who would 
routinely be the staff responsible for placing nasogastric tubes in patients. The Manual 
is  a  well-known  guide  for  nurses  to  deliver  clinically  effective,  patient-focused,  and 
evidence-based care.  

You  raised  concern  about  some  nasogastric  tubes  having  product  instructions  and 
others  not.  Product  instructions  for  the  use  of  nasogastric  decompression/drainage 
tubes would not sit within the remit of NHS England. The Coroner may wish to refer 
this concern to the Medicines and Healthcare products Regulatory Agency (MHRA) as 
they would be the organisation responsible for issuing the relevant instructions.  NHS 
England  will  be  happy  to  support  the  MHRA  with  the  dissemination  of  any  new 
instructions/guidance to relevant healthcare professionals.  

In  your  Report,  you  also  raised  the  concern  that  a  Healthcare  Safety  Investigation 
Branch  independent  report  12019/006  found  that  the  use  of  pH  strips  is  potentially 
unreliable  and  incorrect  X-ray  confirmation  and  interpretation  is  the  most  common 

                                                                                                                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 cause  of  nasogastric  tube  misplacement  incidents.  It  recommended  national 
standardised  competency-based  training  for  nasogastric  tube  placement  and 
confirmation by pH testing.  

The National Institute of Health and Care Excellence (NICE) are the statutory body 
who lead on developing and disseminating clinical guidance and I note that you have 
also sent your Report to them. NHS England will carefully consider NICE’s response 
to you and any actions that may be required from us as a result.  

As to national training provisions around insertion of nasogastric tubes, I asked my 
colleagues from the national Workforce, Training and Education (WTE) Directorate at 
NHS England to consider your Report and the concerns raised.  They advised that 
such  a  training  programme  would  not  come  under  NHS  England’s  remit.  Individual 
NHS Trusts are responsible for the implementation of locally recommended practice 
and  protocols,  including  the  staffing  and  availability  of  workforce.  You  may  wish  to 
engage  with  Frimley  Health  NHS  Foundation  Trust  for  further  information  on  their 
specific practice and protocols regarding placement of nasogastric tubes.  

What is clear from your Report is that there does appear to be some inconsistency of 
understanding  and  awareness  around  instructions  or  guidance  on  the  insertion  of 
nasogastric decompression tubes. Considering this, NHS England has asked regional 
colleagues to ensure that they raise awareness of what happened in Reginald’s care, 
the concerns raised in your Repot and the learnings with their regional Integrated Care 
Boards (ICBs).  ICBs are responsible for planning and commissioning health services 
for their local populations and will be able to engage with their respective local NHS 
Trusts  and  NHS  providers  on  this  matter  to  ensure  that  there  is  understanding  of 
guidance and information available.  

I would also like to provide further assurances on national NHS England work taking 
place around the Reports to Prevent Future Deaths. All reports received are discussed 
by  the  Regulation  28  Working  Group,  comprising  Regional  Medical  Directors,  and 
other clinical and quality colleagues from across the regions. This ensures that key 
learnings and insights around preventable deaths are shared across the NHS at both 
a national and regional level and helps us pay close attention to any emerging trends 
that may require further review and action.  

Thank you for bringing these important patient safety issues to my attention and please 
do not hesitate to contact me should you need any further information. 

Yours sincerely, 

National Medical Director
Response from National Institute for Health and Care Excellence (PDF)
2nd Floor 
2 Redmond Place 
London 
E20 1JQ 
United Kingdom 

27 October 2023 

Caroline Topping 
HM Coroner’s Court 
Station Approach 
Woking 
Surrey 
GU22 7AP 

Dear Ms Topping, 

I write in response to your regulation 28 report regarding the sad death of Reginald Edwin 
Bourn. I would like to express my sincerest condolences to his family. 

We have considered the circumstances surrounding Mr Bourn’s death and I have addressed 
below the matters of concern on which NICE can comment. 

Lack of national guidance on the placement of nasogastric decompression tubes 

In your report you explained that while there is national guidance in relation to the placement 
of nasogastric feeding tubes, there is not the same for nasogastric decompression tubes. 

NICE has not published guidance on the management of small bowel obstruction, and so 
has not made recommendations on nasogastric decompression. Your report has been 
shared with our topic selection and prioritisation team to consider the need for NICE 
guidance in this area. 

Healthcare Safety Investigation Branch (HSIB) report on the placement of nasogastric 
feeding tubes 

You expressed concern that the HSIB made recommendations on the placement of 
nasogastric feeding tubes, having found that the use of pH strips is potentially unreliable and 
that incorrect X-ray confirmation and interpretation is the most common cause of 
misplacement incidents.  

In the NICE guideline on nutrition support for adults: oral nutrition support, enteral tube 
feeding and parenteral nutrition [CG32] we recommend that:  

The position of all nasogastric tubes should be confirmed after placement and before 
each use by aspiration and pH graded paper (with X-ray if necessary) as per 
the advice from the National Patient Safety Agency (2011); further patient safety 
alerts for nasogastric tubes have also been issued in 2013 and 2016. Local protocols 
should address the clinical criteria that permit enteral tube feeding. These criteria 
include how to proceed when the ability to make repeat checks of the tube position is 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 limited by the inability to aspirate the tube, or the checking of pH is invalid because of 
gastric acid suppression. (Recommendation 1.7.17) 

Both the HSIB’s report on the placement of nasogastric tubes and your report concerning the 
death of Mr Bourn have been shared with NICE’s guideline surveillance team to see if an 
update to this recommendation is required.  

Instructions for nasogastric decompression tubes 

On your point that ‘feeding tubes have instructions both as to how to insert them and as to 
how to ensure that they are correctly placed [while] decompression tubes have neither’, we 
believe the Medicines and Healthcare products Regulatory Agency (MHRA) would be best 
placed to consider this issue as the UK’s regulator of medical devices.  

Yours sincerely, 

Chief executive 

                                                                                                                                 Page | 2

Related reports

Other reports by Caroline Topping

See all →

More reports categorised “Hospital Death (Clinical Procedures and medical management) related deaths”

See all →

Track Hospital Death (Clinical Procedures and medical management) related deaths

See every Prevention of Future Deaths report matching Hospital Death (Clinical Procedures and medical management) related deaths, and how often a new one appears.

What would an alert for this have sent me? Search the full text

Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.

These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.